Biotech

Latest Articles

Editas capitalize Vertex Cas9 licensing rights for $57M

.Against the background of a Cas9 patent struggle that refuses to pass away, Editas Medicine is mone...

Ultragenyx changes gene therapy application to dial up efficacy

.A minority of clients taking Ultragenyx Drug's Wilson disease gene treatment UX701 have actually co...

Biopharma unemployment fee maintains in Q3: Ferocious Biotech study

.As summer season warm looks to cool down winds, wishes that this year would bring common business r...

J &amp J drops stage 2 dengue candidate in latest shift coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own transmittable disease pipeline has actually decl...

Relay loses 10% of staff after earlier layoffs in July

.Precision medication biotech Relay Therapies is actually shedding around 10% of its own labor force...

Pentixapharm scores $22M IPO to advance radiopharma trials

.Pentixapharm has generated nearly twenty million europeans ($ 22 million) from an IPO, along with t...

Lundbeck water faucets Charles Waterway for AI-enabled neuro medicine finding

.Lundbeck has utilized Charles River Laboratories' artificial intelligence capacities to help the fi...

Big pharma, biotech 'will not essentially be symbiotic' in AI: S&ampP

.Large Pharma is actually committing highly in AI to slash progression timetables and foster innovat...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Bio has actually roped in $115 thousand in series B funds to accelerate preclinical antitox...

IGM rotates from cancer cells to autoimmune, shaking up C-suite

.IGM Biosciences finished in 2014 laying off team and improving its own cancer cells pipeline. Now, ...

Shattuck axes CD47 plan over unstable efficiency records, lays off 40% of personnel and also drops Ono deal

.Shattuck Labs has actually knocked yet another nail in to the coffin of CD47. After observing a "mo...

BioMarin goes Backpacking, striking RNA cope with biotech

.BioMarin is including combustion to the R&ampD fire, blowing a fit with CAMP4 Therapeutics for civi...

Cash- strapped Gritstone begins search for strategic options as cancer injection data underwhelm

.Gritstone biography has brought in banks to check out "potential value-maximizing strategies" after...

Kailera launches with $400M collection A, 4 Mandarin weight problems medications

.Kailera Rehabs has actually launched right into the more and more packed excessive weight space wit...

Metsera partner with Amneal to latch down GLP-1 source

.Along with very early phase 1 data today out in bush, metabolic disease ensemble Metsera is actuall...

Rivus posts records to back up muscle-sparing weight problems medicine insurance claims

.Rivus Pharmaceuticals has revealed the data behind its own stage 2 weight problems succeed in cardi...

BMS spends $110M to create T-cell therapy deal, assisting Main purchase time to advance prioritized pipeline

.Bristol Myers Squibb is actually spending Prime Medication $110 million ahead of time to develop re...

Generate increases one more $1B-plus Large Pharma alliance

.Novartis has actually printer inked a package potentially worth much more than $1 billion along wit...

Metsera GLP-1 information piece uncovers 7.5% weight-loss at 36 days

.Lately debuted Metsera is actually unfolding some period 1 record for its GLP-1 receptor agonist, u...

Flagship really hopes biotechs flock to Mirai to increase hereditary meds

.Amidst the hereditary medicines arms race, Front runner Pioneering is actually unveiling a new prov...